Munich-based chemical group WACKER has conferred the Alexander Wacker Innovation Award on Rachela Mohr and Dr. Helmut Reuscher for developing CAVACURMIN®. The dietary supplement contains curcumin, an extract from turmeric, complexed with cyclodextrins. It therefore exhibits excellent dispersibility properties, which means it can be absorbed and used by the body much faster than competing products. The €10,000 award was presented yesterday at this year’s “WACKER Innovation Days” research symposium in Burghausen.
Curcumin, the biologically active constituent in turmeric, is a powerful antioxidant that has been shown to exhibit anti-inflammatory and antibacterial properties. However, as it is not water-soluble, it is not readily absorbed in the human bloodstream. “To improve this, we use a trick by complexing curcumin extract with our cyclodextrins,” explains Rachela Mohr, who is responsible for marketing bioactive ingredients at WACKER.
“The importance of high bioavailability in dietary supplements is on the rise among our customers. We are very proud that our innovative cyclodextrin platform is finding more widespread use and allows us to make a contribution to the development of enhanced dietary supplements,” said Dr. Helmut Reuscher, who developed CAVACURMIN®.
WACKER’s CAVACURMIN® is a free-flowing, dispersible powder and so can be processed not only to dry or powdered dietary supplements, such as tablets, capsules and energy bars, but also to functional beverages.